Messoud Ashina
Professor, University of Copenhagen and Associate Editor at Brain
Professor of Neurology, Danish Headache Center, Head of Danish Knowledge Center on Headache Disorders, Past President of the International Headache Society
Articles
-
Sep 4, 2024 |
nejm.org | Messoud Ashina
AbstractTargeting pituitary adenylate cyclase–activating polypeptide (PACAP) is a new avenue for treating migraine. The efficacy and safety of intravenous Lu AG09222, a humanized monoclonal antibody directed against the PACAP ligand, for migraine prevention are unclear. In a phase 2, double-blind, randomized, placebo-controlled trial, we enrolled adult participants (18 to 65 years of age) with migraine for whom two to four previous preventive treatments had failed to provide a benefit.
-
Feb 5, 2024 |
linkedin.com | Messoud Ashina
Results from the nationwide headache in Denmark (HINDER) panel: inadequate delivery of headache care in DK that provides free and universal coverage for all its residents. Read about the implications👇
-
Jul 26, 2023 |
thelancet.com | Patricia Pozo-Rosich |Universitat Autònoma |Jessica Ailani |Messoud Ashina
Summary In this study, we aimed to evaluate the efficacy, safety, and tolerability of atogepant for the preventive treatment of chronic migraine. We did this randomised, double-blind, placebo-controlled, phase 3 trial at 142 clinical research sites across the USA, the UK, Canada, China, Czech Republic, Denmark, France, Germany, Italy, Japan, South Korea, Poland, Russia, Spain, Sweden, and Taiwan.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →X (formerly Twitter)
- Followers
- 1K
- Tweets
- 600
- DMs Open
- No
RT @bidmcheadache: New study: IV infusion of substance P induced headache and arterial dilation in healthy adults. 71% reported #headache v…
RT @lundbeckfonden: Congratulations to the LF Fellows 2025! We are proud to announce that seven outstanding scientists have been awarded t…
RT @hmru_cph: 🚨 New publication alert! 🧠 Our study just out in @braincomms identifies clinical predictors of response to erenumab for migra…